125 related articles for article (PubMed ID: 16585162)
1. N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer.
Kim MS; Yamashita K; Baek JH; Park HL; Carvalho AL; Osada M; Hoque MO; Upadhyay S; Mori M; Moon C; Sidransky D
Cancer Res; 2006 Apr; 66(7):3409-18. PubMed ID: 16585162
[TBL] [Abstract][Full Text] [Related]
2. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation.
Dong SW; Cui YT; Zhong RR; Liang DC; Liu YM; Wang YG; He Z; Wang S; Liang SJ; Zhang P
Clin Lab; 2012; 58(1-2):41-51. PubMed ID: 22372344
[TBL] [Abstract][Full Text] [Related]
4. A promoter methylation pattern in the N-methyl-D-aspartate receptor 2B gene predicts poor prognosis in esophageal squamous cell carcinoma.
Kim MS; Yamashita K; Chae YK; Tokumaru Y; Chang X; Zahurak M; Osada M; Park HL; Chuang A; Califano JA; Sidransky D
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6658-65. PubMed ID: 18006766
[TBL] [Abstract][Full Text] [Related]
5. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G
Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383
[TBL] [Abstract][Full Text] [Related]
6. Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma.
Haruki S; Imoto I; Kozaki K; Matsui T; Kawachi H; Komatsu S; Muramatsu T; Shimada Y; Kawano T; Inazawa J
Carcinogenesis; 2010 Jun; 31(6):1027-36. PubMed ID: 20200074
[TBL] [Abstract][Full Text] [Related]
7. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma.
Ito T; Shimada Y; Hashimoto Y; Kaganoi J; Kan T; Watanabe G; Murakami Y; Imamura M
Cancer Res; 2003 Oct; 63(19):6320-6. PubMed ID: 14559819
[TBL] [Abstract][Full Text] [Related]
8. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma.
Ko JM; Chan PL; Yau WL; Chan HK; Chan KC; Yu ZY; Kwong FM; Miller LD; Liu ET; Yang LC; Lo PH; Stanbridge EJ; Tang JC; Srivastava G; Tsao SW; Law S; Lung ML
Mol Cancer Res; 2008 Apr; 6(4):592-603. PubMed ID: 18403638
[TBL] [Abstract][Full Text] [Related]
9. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.
Yamashita K; Kim MS; Park HL; Tokumaru Y; Osada M; Inoue H; Mori M; Sidransky D
Mol Cancer Res; 2008 Jan; 6(1):31-41. PubMed ID: 18234960
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.
Mao WM; Li P; Zheng QQ; Wang CC; Ge MH; Hu FJ; Fang XH; Dong ZM; Ling ZQ
Arch Med Res; 2011 Apr; 42(3):182-8. PubMed ID: 21722812
[TBL] [Abstract][Full Text] [Related]
11. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma.
Yamashita K; Upadhyay S; Osada M; Hoque MO; Xiao Y; Mori M; Sato F; Meltzer SJ; Sidransky D
Cancer Cell; 2002 Dec; 2(6):485-95. PubMed ID: 12498717
[TBL] [Abstract][Full Text] [Related]
13. c-Myc inhibits TP53INP1 expression via promoter methylation in esophageal carcinoma.
Weng W; Yang Q; Huang M; Qiao Y; Xie Y; Yu Y; jing A; Li Z
Biochem Biophys Res Commun; 2011 Feb; 405(2):278-84. PubMed ID: 21219856
[TBL] [Abstract][Full Text] [Related]
14. Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma.
Zhu C; Qin YR; Xie D; Chua DT; Fung JM; Chen L; Fu L; Hu L; Guan XY
Oncogene; 2009 Aug; 28(31):2821-8. PubMed ID: 19525977
[TBL] [Abstract][Full Text] [Related]
15. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
[TBL] [Abstract][Full Text] [Related]
16. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a novel tumor-suppressor gene PLC delta 1 at 3p22 in esophageal squamous cell carcinoma.
Fu L; Qin YR; Xie D; Hu L; Kwong DL; Srivastava G; Tsao SW; Guan XY
Cancer Res; 2007 Nov; 67(22):10720-6. PubMed ID: 18006814
[TBL] [Abstract][Full Text] [Related]
18. The N-methyl-D-aspartate receptor type 2A is frequently methylated in human colorectal carcinoma and suppresses cell growth.
Kim MS; Chang X; Nagpal JK; Yamashita K; Baek JH; Dasgupta S; Wu G; Osada M; Woo JH; Westra WH; Trink B; Ratovitski EA; Moon C; Sidransky D
Oncogene; 2008 Mar; 27(14):2045-54. PubMed ID: 17922030
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
Long C; Yin B; Lu Q; Zhou X; Hu J; Yang Y; Yu F; Yuan Y
Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
Clin Cancer Res; 2003 Apr; 9(4):1441-5. PubMed ID: 12684417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
